The cause of multiple sclerosis is not well understood. In fact, it’s not understood at all, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
The cause of multiple sclerosis is not well understood. In fact, it’s not understood at all, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Has there been any recent progress in understanding causes behind multiple sclerosis?
The cause of MS [multiple sclerosis] is not well understood. In fact, it’s not understood at all. There are some theories that have popped up over the years. Many years ago they talked about a canine distemper virus. In other years, they talked about other problems like Esptein-Barr virus. But, so far nothing has been discovered that actually triggers off MS. More and more, investigators are looking into genetics. MS is not a hereditary disease, but it seems to occur more frequently in certain families. So, families are being studied. Certainly, genetic profiles are being studied. There’s a doctor, Sergio Baranzini, PhD, professor in residence of Neurology at the University of California, San Francisco Institute for Human Genetics, who just spoke at our annual meeting out in Seattle, who is doing a lot of interesting work in genetics. Probably in the next few years, we may start seeing more and more information about risks for MS—high risk versus low risk. Certain medications that might be more appropriate for someone based on a genetic profile.
We know that in people as they age in MS, things change. So, we’re not sure if the disease occurs later in life, will it be different than if it occurs in a child because there are pediatric MS cases now. I think with the technology we have and the wisdom that’s out there in the community, we will see some more answers, but right now, no, unfortunately.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More